Bloodbuy, a healthcare software and services company focused on developing cloud-based technologies that transform how biological products are managed and disseminated, today announced that it has entered into an agreement with Cerus Corporation (NASDAQ: CERS) to offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT® Fibrinogen Complex, or “IFC”) via the Bloodbuy online marketplace.

Blood Bank Computer Systems, Inc. (BBCS) today announces a new partnership with Bloodbuy.  Through this partnership, BBCS and Bloodbuy will work to integrate BBCS’ newly released, ForLife Biologics Platform™ with Bloodbuy®.  This integration will enable blood center customers to engage with their national resource sharing counterparties seamlessly, remove existing manual data transfer processes and enhance user productivity and data quality by eliminating opportunities for human error, all while improving user satisfaction by automating highly repetitive data transfer tasks. 

Providence, R.I. — Brown University — Students traveled near and far to participate in the first residential week in Providence which kicked off with a keynote address from Chris Godfrey, an alumnus of the very first Healthcare Leadership cohort. Since graduating from Brown, Godfrey founded Bloodbuy, a software and services company focused on developing cloud-based technologies that vastly improve how biological products are managed and disseminated. In 2016, Bloodbuy was named the first winner of the Harvard Business School-Harvard Medical School Health Acceleration Challenge.

Bloodbuy wins Cardinal Health Clinical Laboratory Workflow Innovation Award. The award was presented to Bloodbuy during Cardinal Health’s annual gathering of healthcare suppliers, manufacturers, and industry partners. Cardinal Health, Inc. (NYSE: CAH) provides medical products to over 75 percent of hospitals in the United States and is the 14th highest revenue generating company in the United States.

Barcelona, Spain, July 23, 2020 - Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), the leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, today announced it has acquired 10% of Bloodbuy (BloodSolutions, LLC), a cloud-based marketplace that facilitates buying and selling of blood components in the U.S.

Premier and Bloodbuy conducted the nationwide survey of independent blood centers to assess the impact of canceled blood drives and altered utilization patterns, in connection with public health measures taken to contain the spread of COVID-19.

Dallas-based Bloodbuy is now working with over 150 hospitals to optimize their blood supply. Bloodbuy’s largest financial backers include North Carolina-based Premier, Inc. (NASDAQ: PINC) and Providence St. Joseph Health System. The company’s founder & CEO, Chris Godfrey, sat down with the Dallas Business Journal to talk about where the company is headed next.

Approximately 36,000 units of red blood cells are needed every day in the US, according to the Red Cross. A single car accident victim can require up to 100 pints of blood. Many hospitals, however, face recurring blood shortages due to the localized nature of blood supply and distribution.

Tech Titans, the largest technology trade association in Texas, in conjunction with the Dallas Business Journal, have announced Bloodbuy as the winner of the 2017 Tech Titans Emerging Company Innovation Award!

While an ice storm didn’t freeze out fans from Super Bowl 45, held in 2011 at Cowboys Stadium, the Pittsburgh Steelers and local hospitals saw big losses.

There’s something new and exciting in the world of blood banking and medical laboratory medicine. It’s a unique approach to matching the availability of blood products to the demand for those same products and it’s catching the attention of medical laboratory directors and blood bankers in many of the nation’s hospitals.

Bloodbuy is featured in the 2016 Design Issue of WIRED magazine, currently on newsstands.  Pick up a print edition of the globally acclaimed technology magazine and read about Bloodbuy in the article entitled Priceline for Platelets.  The article focuses on Bloodbuy's cloud-based technology platform, which is being utilized to connect hospitals and blood centers across the country in an effort to create a more cohesive network, and thereby efficient, blood supply ecosystem.

Earlier this year, the White House made a bold bid against cancer, announcing a new, nationwide “Moonshot” initiative to do away with the disease — once and for all. Mark Zuckerberg also made headlines recently by promising to bankroll research efforts.  Billions of dollars in increased funding and more brainstorming toward a cure is a very good thing. With the costs of cancer care hovering around $157 billion a year, heart disease/stroke at $315.4 billion and the human toll of both at 1.2 million per year, these unrelenting illnesses need the most attention.